DH blocked NHS Direct statement on homeopathy

The Department of Health blocked NHS Direct from telling the public that there is “no good quality clinical evidence” to show that homeopathy is more than a placebo.

Janssen team partners with NHS to find dementia solutions

An entrepreneurial team within Janssen’s R&D operation is working with the NHS to promote innovative dementia care. Janssen Healthcare Innovation and the...

Sexual health in UK is worsening

Funding pressures on sexual health services are driving an increase in sexually transmitted infections (STIs) and unplanned pregnancies, a new report warns.

Mid Staffs report emphasises ‘transparency’

The public enquiry report on preventable deaths at Stafford General Hospital has placed emphasis on improving the ‘transparency’ and regulation of the NHS.

Local providers key for health and wellbeing boards

Health and wellbeing boards (HWBs) across the country will have to work closely with local providers of health and care services if they are to be successful, a new report warns.

Lords bill aims to restore Health Secretary’s duty to provide NHS

A new House of Lords bill aims to restore the legal duty of the Health Secretary to “secure provision” of NHS services.

DH plans rollout of personal health budgets

The Department of Health has outlined plans to make personal health budgets (PHBs) available to the 56,000 people receiving NHS continuing healthcare from April 2014.

QALY drug appraisal system found invalid

The Quality Adjusted Life Years (QALY) system for deciding which drugs should be available on the NHS is worthless, according to a European Commission report.

Board authorises second wave CCGs

The NHS Commissioning Board has authorised a further 67 clinical commissioning groups to take on local responsibilities for healthcare budgets and services.

UK to launch first shingles vaccination programme in Europe

The UK is launching the first national shingles immunisation programme in the EU.

Latest articles

AveXis presents new data at 2019 EPNS Congress showing significant therapeutic benefit of Zolgensma

AveXis presents Zolgensma® data at EPNS

AveXis has presented new data on Zolgensma® at the 2019 European Paediatric Neurology Society (EPNS) Congress. The data continue to show the significant therapeutic...
image of a hospital and ambulance showing poor diabetes control costs the NHS £3bn in avoidable treatment

Poor diabetes control costs the NHS £3bn in avoidable treatment

New research finds that poor diabetes control costs the NHS £3bn in potentially avoidable hospital treatment in England. The findings, being presented at this year’s...
Takeda's Takhzyro ®▼ recommended on NHS for hereditary angiodema

Takeda’s Takhzyro®▼ recommended on NHS for hereditary angioedema

Takeda's Takhzyro®▼ recommended on NHS for hereditary angioedema (HAE) in a Final Appraisal Determination (FAD). The health technology appraisal body in England and Wales,...

Popular articles

AveXis presents new data at 2019 EPNS Congress showing significant therapeutic benefit of Zolgensma

Data-driven marketing in pharma: The future is here

Data-driven marketing in pharma, Pamela Walker and Joshua Hull explain why personalisation is the key to unlocking opportunity via pharma digital marketing. In pharma, ‘digital’...
Takeda's Takhzyro ®▼ recommended on NHS for hereditary angiodema

Takeda’s Takhzyro®▼ recommended on NHS for hereditary angioedema

Takeda's Takhzyro®▼ recommended on NHS for hereditary angioedema (HAE) in a Final Appraisal Determination (FAD). The health technology appraisal body in England and Wales,...
New report on access to cutting edge medicines

New report on access to cutting edge medicines

A new cross-party report is urging the life science community to work together and grasp the opportunity to speed up access to cutting-edge medicines...
Early signs of adult type 2 diabetes visible in 8 year olds

Early signs of adult type 2 diabetes visible in 8 year olds

Early signs of adult type 2 diabetes can be seen in children as young as 8 years old, decades before it is likely to...
SAnofi and Abbott partner to improve diabetes management with technology

Sanofi & Abbott in diabetes management partnership

Sanofi and Abbott have partnered to integrate glucose sensing and insulin delivery technologies to help to further simplify how people with diabetes manage their...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription